Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 3/1998

01-05-1998

Reduced expression and rare genomic alteration of nm23-H1in human hepatocellular carcinoma and hepatoma cell lines

Authors: Yoshinori Fujimoto, Takaaki Ohtake, Hiroyuki Nishimori, Katsuya Ikuta, Motoyuki Ohhira, Minoru Ono, Yutaka Kohgo

Published in: Journal of Gastroenterology | Issue 3/1998

Login to get access
Metadata
Title
Reduced expression and rare genomic alteration of nm23-H1in human hepatocellular carcinoma and hepatoma cell lines
Authors
Yoshinori Fujimoto
Takaaki Ohtake
Hiroyuki Nishimori
Katsuya Ikuta
Motoyuki Ohhira
Minoru Ono
Yutaka Kohgo
Publication date
01-05-1998
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 3/1998
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s005350050098

Other articles of this Issue 3/1998

Journal of Gastroenterology 3/1998 Go to the issue

OriginalPaper

Altered hepatic hemodynamics and improved liver function following intrahepatic vascular infusion of prostaglandin E1

OriginalPaper

Clinical significance of serum levels of CD44 variant exons 8–10 protein in colorectal cancer

OriginalPaper

Effects of transjugular intrahepatic portosystemic shunt (TIPS) on esophageal motor function and gastroesophageal reflux

OriginalPaper

Endoscopic findings in transplanted allo-intestine of rats after discontinuance of immunosuppressive agent

OriginalPaper

TGF-β isoforms in alcoholic liver disease

Review

Ulcerative colitis and Crohn's disease—susceptibility genes and clinical patterns
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits